{"transactions":[{"id":903278,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:09:09.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8025,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8025},"source":{"system":"sec-edgar","filing":"0000875045-26-000028","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000028/form4.xml","form_type":"4"}},{"id":913148,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":7494,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":3746},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913147,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1802,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1802},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913146,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":1635},"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913145,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1132,"price":201.18,"value":227735.76,"ownership":{"direct":true},"balance_after":22358.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913144,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":3746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23490.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913143,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":666,"price":201.18,"value":133985.88,"ownership":{"direct":true},"balance_after":19744.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913142,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1802,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20410.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913141,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":791,"price":201.18,"value":159133.38,"ownership":{"direct":true},"balance_after":18608.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":913140,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2026-02-10T21:58:07.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025."}],"balance_after":19399.7673,"source":{"system":"sec-edgar","filing":"0000875045-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000017/form4.xml","form_type":"4"}},{"id":1272568,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:43:50.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2159},"source":{"system":"sec-edgar","filing":"0001127602-25-004456","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004456/form4.xml","form_type":"4"}},{"id":1272567,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-12T22:43:50.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":634,"price":142.54,"value":90370.36,"ownership":{"direct":true},"balance_after":17598.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-004456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004456/form4.xml","form_type":"4"}},{"id":1272566,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-12T22:43:50.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18232.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-004456","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004456/form4.xml","form_type":"4"}},{"id":1277522,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":3604,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1801},"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277521,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":1635,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":1635},"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277520,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":11240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":11240,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":11240},"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277519,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":560,"price":141.35,"value":79156.0,"ownership":{"direct":true},"balance_after":16073.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277518,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":1801,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16633.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277517,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":480,"price":141.35,"value":67848.0,"ownership":{"direct":true},"balance_after":14832.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1277516,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2025-02-10T23:44:10.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2024."}],"balance_after":15312.1006,"source":{"system":"sec-edgar","filing":"0001127602-25-003955","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003955/form4.xml","form_type":"4"}},{"id":1631000,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":1879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1879},"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630999,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":1879,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630998,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":3197,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3197},"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630997,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":729,"price":219.08,"value":159709.32,"ownership":{"direct":true},"balance_after":13583.716,"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630996,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14312.716,"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630995,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1535,"price":219.08,"value":336287.8,"ownership":{"direct":true},"balance_after":12805.716,"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1630994,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-22T02:36:10.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":3197,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14340.716,"source":{"system":"sec-edgar","filing":"0001127602-24-006217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006217/form4.xml","form_type":"4"}},{"id":1647473,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T23:14:22.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":2158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":2159,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2158},"source":{"system":"sec-edgar","filing":"0001127602-24-004805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004805/form4.xml","form_type":"4"}},{"id":1647472,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-13T23:14:22.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":634,"price":240.98,"value":152781.32,"ownership":{"direct":true},"balance_after":11143.716,"source":{"system":"sec-edgar","filing":"0001127602-24-004805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004805/form4.xml","form_type":"4"}},{"id":1647471,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-13T23:14:22.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":2158,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11777.716,"source":{"system":"sec-edgar","filing":"0001127602-24-004805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004805/form4.xml","form_type":"4"}},{"id":1652230,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:14:54.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":3270,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":1635},"source":{"system":"sec-edgar","filing":"0001127602-24-004310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004310/form4.xml","form_type":"4"}},{"id":1652229,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:14:54.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":5405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":5405,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":5405},"source":{"system":"sec-edgar","filing":"0001127602-24-004310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004310/form4.xml","form_type":"4"}},{"id":1652228,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-10T01:14:54.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":498,"price":240.3,"value":119669.4,"ownership":{"direct":true},"balance_after":9619.716,"source":{"system":"sec-edgar","filing":"0001127602-24-004310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004310/form4.xml","form_type":"4"}},{"id":1652227,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2024-02-10T01:14:54.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":1635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10117.716,"source":{"system":"sec-edgar","filing":"0001127602-24-004310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004310/form4.xml","form_type":"4"}},{"id":1665787,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:30:27.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":3197,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3197},"source":{"system":"sec-edgar","filing":"0001127602-24-002805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002805/form4.xml","form_type":"4"}},{"id":1909164,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-05-03T00:05:14.000Z","date":"2023-04-28","kind":"sale","planned":true,"acquired":false,"shares":2681,"price":300,"value":804300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2023."}],"balance_after":8482.716,"source":{"system":"sec-edgar","filing":"0001127602-23-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223014146/form4.xml","form_type":"4"}},{"id":2001565,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:54:26.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":1590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":3386,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1590},"source":{"system":"sec-edgar","filing":"0001127602-23-006507","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006507/form4.xml","form_type":"4"}},{"id":2001564,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:54:26.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":1792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":4976,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1792},"source":{"system":"sec-edgar","filing":"0001127602-23-006507","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006507/form4.xml","form_type":"4"}},{"id":2001563,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-22T21:54:26.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":867,"price":278.38,"value":241355.46,"ownership":{"direct":true},"balance_after":9280.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-006507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006507/form4.xml","form_type":"4"}},{"id":2001562,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-22T21:54:26.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":1792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11072.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-006507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006507/form4.xml","form_type":"4"}},{"id":2017932,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"other","acquired":false,"shares":1384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to\nvest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1384},"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017931,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":1132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020.  The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to\nvest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1384,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1132},"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017930,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":2158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":4317,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2158},"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017929,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":2110,"price":286.3,"value":604093.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 27, 2023."}],"balance_after":10147.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017928,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":548,"price":286.3,"value":156892.4,"ownership":{"direct":true},"balance_after":12257.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017927,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":1132,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12805.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017926,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":648,"price":286.3,"value":185522.4,"ownership":{"direct":true},"balance_after":11673.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2017925,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-02-15T02:44:01.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":2158,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12321.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-005272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005272/form4.xml","form_type":"4"}},{"id":2023665,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:45:36.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":4905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023."}],"balance_after":4905,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":4905},"source":{"system":"sec-edgar","filing":"0001127602-23-004577","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004577/form4.xml","form_type":"4"}},{"id":2044273,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2023-01-27T22:53:51.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":4452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023."}],"balance_after":10163.0168,"source":{"system":"sec-edgar","filing":"0001127602-23-002479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002479/form4.xml","form_type":"4"}},{"id":2090470,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-12-13T01:00:05.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":5610,"price":300.11,"value":1683617.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2022."}],"balance_after":5711.0168,"source":{"system":"sec-edgar","filing":"0001127602-22-027348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222027348/form4.xml","form_type":"4"}},{"id":2380137,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:15:01.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":1995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":6768,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1995},"source":{"system":"sec-edgar","filing":"0001127602-22-006264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006264/form4.xml","form_type":"4"}},{"id":2380136,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:15:01.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":8763,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1387},"source":{"system":"sec-edgar","filing":"0001127602-22-006264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006264/form4.xml","form_type":"4"}},{"id":2380135,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-23T21:15:01.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":616,"price":209.79,"value":129230.64,"ownership":{"direct":true},"balance_after":11218.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-006264","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006264/form4.xml","form_type":"4"}},{"id":2380134,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-23T21:15:01.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1387,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11834.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-006264","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006264/form4.xml","form_type":"4"}},{"id":2395623,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2516,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1633},"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395622,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":4149,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":879},"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395621,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1505},"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395620,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1505,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":793},"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395619,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":584,"price":214.59,"value":125320.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 21, 2022."}],"balance_after":10447.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395618,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":390,"price":214.59,"value":83690.1,"ownership":{"direct":true},"balance_after":11031.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395617,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":879,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11421.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395616,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":278,"price":214.59,"value":59656.02,"ownership":{"direct":true},"balance_after":10542.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2395615,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-02-15T21:16:33.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":793,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10820.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-004991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004991/form4.xml","form_type":"4"}},{"id":2399483,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:27:52.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":6475,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-22-004806","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004806/form4.xml","form_type":"4"}},{"id":2429261,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2022-01-21T21:48:41.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":1941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019.  The shares will vest on February 12, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 71.5888 shares, 14,2341 shares, 10.4331 shares and .0001 share acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021, 6/30/2021, 9/30/2021 and 12/31/2021, respectively."}],"balance_after":10027.6165,"source":{"system":"sec-edgar","filing":"0001127602-22-001863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001863/form4.xml","form_type":"4"}},{"id":2844480,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:09:16.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10150,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":10150},"source":{"system":"sec-edgar","filing":"0001127602-21-006976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006976/form4.xml","form_type":"4"}},{"id":2856325,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5028,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1444},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856324,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6472,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1068},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856323,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2298,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1332},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856322,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3630,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":964},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856321,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1005},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856320,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1005,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":891},"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856319,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":474,"price":278.03,"value":131786.22,"ownership":{"direct":true},"balance_after":7990.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856318,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":428,"price":278.03,"value":118996.84,"ownership":{"direct":true},"balance_after":8464.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856317,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":396,"price":278.03,"value":110099.88,"ownership":{"direct":true},"balance_after":8892.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856316,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1068,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9288.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856315,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":964,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8220.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856314,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":891,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7256.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2856313,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-02-17T21:56:31.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":884,"price":278.03,"value":245778.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 29, 2021."}],"balance_after":6365.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-006268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006268/form4.xml","form_type":"4"}},{"id":2891219,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2021-01-29T21:44:51.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":2558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2018.  The shares will vest on February 12, 2021."}],"balance_after":7249.3603,"source":{"system":"sec-edgar","filing":"0001127602-21-002975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221002975/form4.xml","form_type":"4"}},{"id":3070417,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-08-04T20:12:26.000Z","date":"2020-07-31","kind":"other","acquired":false,"shares":216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-08-01","underlying":"Common Stock","underlying_shares":216},"source":{"system":"sec-edgar","filing":"0001127602-20-022686","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220022686/form4.xml","form_type":"4"}},{"id":3070416,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-08-04T20:12:26.000Z","date":"2020-07-31","kind":"exercise","acquired":false,"shares":212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":216,"derivative":{"exercise_price":0,"expiration_date":"2020-08-01","underlying":"Common Stock","underlying_shares":212},"source":{"system":"sec-edgar","filing":"0001127602-20-022686","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220022686/form4.xml","form_type":"4"}},{"id":3070415,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-08-04T20:12:26.000Z","date":"2020-07-31","kind":"tax_withholding","acquired":false,"shares":95,"price":274.69,"value":26095.55,"ownership":{"direct":true},"balance_after":4691.3603,"source":{"system":"sec-edgar","filing":"0001127602-20-022686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220022686/form4.xml","form_type":"4"}},{"id":3070414,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-08-04T20:12:26.000Z","date":"2020-07-31","kind":"exercise","acquired":true,"shares":212,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4786.3603,"source":{"system":"sec-edgar","filing":"0001127602-20-022686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220022686/form4.xml","form_type":"4"}},{"id":3070413,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-08-04T20:12:26.000Z","date":"2020-07-31","kind":"tax_withholding","acquired":false,"shares":128,"price":274.69,"value":35160.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15.4542 shares, 69.717 shares and 14.1891 shares acquired under the Biogen Inc. employee stock purchase plan on 12/31/2019, 3/31/2020 and 6/30/2020, respectively."}],"balance_after":4574.3603,"source":{"system":"sec-edgar","filing":"0001127602-20-022686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220022686/form4.xml","form_type":"4"}},{"id":3272145,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":7540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":7540,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":7540},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272144,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":1240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":4594,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1240},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272143,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5834,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1056},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272142,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1896,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":918},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272141,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2814,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":974},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272140,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units will vest in 2 annual installments.  One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-12","underlying":"Common Stock","underlying_shares":1517},"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272139,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":418,"price":331.76,"value":138675.68,"ownership":{"direct":true},"balance_after":4603,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272138,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1056,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5021,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272137,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":286,"price":331.76,"value":94883.36,"ownership":{"direct":true},"balance_after":3965,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272136,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":974,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4251,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272135,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":455,"price":331.76,"value":150950.8,"ownership":{"direct":true},"balance_after":3277,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3272134,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Common Stock","published_at":"2020-02-14T23:32:59.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3732,"source":{"system":"sec-edgar","filing":"0001127602-20-005779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005779/form4.xml","form_type":"4"}},{"id":3447881,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2019-08-05T20:20:38.000Z","date":"2019-08-01","kind":"other","acquired":false,"shares":247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":428,"derivative":{"exercise_price":0,"expiration_date":"2020-08-01","underlying":"Common Stock","underlying_shares":247},"source":{"system":"sec-edgar","filing":"0001127602-19-026026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219026026/form4.xml","form_type":"4"}},{"id":3447880,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66325,"kind":"person","name":"Gregory Ginger","position":1,"cik":"0001545716","reported_name":"Gregory Ginger","relationship":{"officer":true,"officer_title":"EVP, Human Resources"}}],"security":"Restricted Stock Unit","published_at":"2019-08-05T20:20:38.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":675,"derivative":{"exercise_price":0,"expiration_date":"2020-08-01","underlying":"Common Stock","underlying_shares":179},"source":{"system":"sec-edgar","filing":"0001127602-19-026026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219026026/form4.xml","form_type":"4"}}],"next_cursor":"2019-08-05T20:20:38.000000Z,3447880"}